Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Aprotinin 10,000 KIU/ml injection BP: UK summary of product characteristics. Reading: Nordic Pharma Limited; 2017.
2. Committee for Medicinal Products for Human Use (CHMP). Assessment report: antifibrinolytics containing aprotinin, aminocaproic acid and tranexamic acid. London: European Medicines Agency; 2013.
3. Mangano DT, Tudor IC, Dietzel C, et al. The risk associated with aprotinin in cardiac surgery. N Eng J Med. 2006;354(4):353–65.
4. Karkouti K, Beattie W, Dattilo K, et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion (Paris). 2006;46(3):327–38.
5. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319–31.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献